Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography

Improving on the current standard

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

To assess whether quantitative visual scoring (QVS) is a better early predictor of progression-free survival (PFS) in patients on chemotherapy for metastatic melanoma using CT than the currently used Response Evaluation Criteria in Solid Tumors (RECIST) standard. Retrospective evaluation of 65 consecutive patients with metastatic melanoma on treatment who had a baseline and follow-up CT after two cycles of therapy. QVS was used to code imaging findings on the radiology reports considering size change, brain metastases, new lesions, mixed lesion response, and the number of organ systems involved. RECIST 1.1 criteria placed patients in the progressive disease, stable disease, or partial response groups. Multiple regression analysis was used to correlate the various independent variables with PFS. The Cox hazard proportions ratio, median survival, and Kaplan-Meier curves of the different prognostic groups were calculated. QVS of size change was found more sensitive in detecting patients deteriorating (57.1% versus 37.5%) or improving (23.8% versus 10.7%), more correlated with the median PFS for the deteriorating (1.8 versus 1.7 months), stable (5.6 versus 4.0 month), and improving (8.3 versus 5.5 months) categories and more predictive of PFS (Cox hazard proportion ratio of 3.070 versus 1.860) than RECIST 1.1 categorization. Multiple regression analysis demonstrated QVS of lesion size correlated most closely with PFS among the variables assessed (r=0.519, p<0.0001). QVS in this study was superior to standard RECIST categorization in terms of discriminating treated metastatic melanoma patients likely to have longer PFS.

Original languageEnglish (US)
Pages (from-to)258-265
Number of pages8
JournalJournal of Digital Imaging
Volume25
Issue number2
DOIs
StatePublished - Apr 2012

Fingerprint

Patient treatment
Disease-Free Survival
Tomography
Tumors
Melanoma
Regression analysis
Hazards
Radiology
Chemotherapy
Therapeutics
Regression Analysis
Brain
Kaplan-Meier Estimate
Imaging techniques
Neoplasm Metastasis
Drug Therapy
Response Evaluation Criteria in Solid Tumors

Keywords

  • Body imaging
  • Cancer detection
  • Clinical oncology
  • Computed tomography
  • Health services research
  • Image analysis
  • Image perception
  • Structured reporting
  • Visual perception

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Radiological and Ultrasound Technology
  • Computer Science Applications
  • Medicine(all)

Cite this

@article{381c28512820422690a20737fd7cafa5,
title = "Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography: Improving on the current standard",
abstract = "To assess whether quantitative visual scoring (QVS) is a better early predictor of progression-free survival (PFS) in patients on chemotherapy for metastatic melanoma using CT than the currently used Response Evaluation Criteria in Solid Tumors (RECIST) standard. Retrospective evaluation of 65 consecutive patients with metastatic melanoma on treatment who had a baseline and follow-up CT after two cycles of therapy. QVS was used to code imaging findings on the radiology reports considering size change, brain metastases, new lesions, mixed lesion response, and the number of organ systems involved. RECIST 1.1 criteria placed patients in the progressive disease, stable disease, or partial response groups. Multiple regression analysis was used to correlate the various independent variables with PFS. The Cox hazard proportions ratio, median survival, and Kaplan-Meier curves of the different prognostic groups were calculated. QVS of size change was found more sensitive in detecting patients deteriorating (57.1{\%} versus 37.5{\%}) or improving (23.8{\%} versus 10.7{\%}), more correlated with the median PFS for the deteriorating (1.8 versus 1.7 months), stable (5.6 versus 4.0 month), and improving (8.3 versus 5.5 months) categories and more predictive of PFS (Cox hazard proportion ratio of 3.070 versus 1.860) than RECIST 1.1 categorization. Multiple regression analysis demonstrated QVS of lesion size correlated most closely with PFS among the variables assessed (r=0.519, p<0.0001). QVS in this study was superior to standard RECIST categorization in terms of discriminating treated metastatic melanoma patients likely to have longer PFS.",
keywords = "Body imaging, Cancer detection, Clinical oncology, Computed tomography, Health services research, Image analysis, Image perception, Structured reporting, Visual perception",
author = "Gottlieb, {Ronald H.} and Krupinski, {Elizabeth A} and Pavani Chalasani and Cranmer, {Lee D}",
year = "2012",
month = "4",
doi = "10.1007/s10278-011-9407-9",
language = "English (US)",
volume = "25",
pages = "258--265",
journal = "Journal of Digital Imaging",
issn = "0897-1889",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - Quantified visual scoring of metastatic melanoma patient treatment response using computed tomography

T2 - Improving on the current standard

AU - Gottlieb, Ronald H.

AU - Krupinski, Elizabeth A

AU - Chalasani, Pavani

AU - Cranmer, Lee D

PY - 2012/4

Y1 - 2012/4

N2 - To assess whether quantitative visual scoring (QVS) is a better early predictor of progression-free survival (PFS) in patients on chemotherapy for metastatic melanoma using CT than the currently used Response Evaluation Criteria in Solid Tumors (RECIST) standard. Retrospective evaluation of 65 consecutive patients with metastatic melanoma on treatment who had a baseline and follow-up CT after two cycles of therapy. QVS was used to code imaging findings on the radiology reports considering size change, brain metastases, new lesions, mixed lesion response, and the number of organ systems involved. RECIST 1.1 criteria placed patients in the progressive disease, stable disease, or partial response groups. Multiple regression analysis was used to correlate the various independent variables with PFS. The Cox hazard proportions ratio, median survival, and Kaplan-Meier curves of the different prognostic groups were calculated. QVS of size change was found more sensitive in detecting patients deteriorating (57.1% versus 37.5%) or improving (23.8% versus 10.7%), more correlated with the median PFS for the deteriorating (1.8 versus 1.7 months), stable (5.6 versus 4.0 month), and improving (8.3 versus 5.5 months) categories and more predictive of PFS (Cox hazard proportion ratio of 3.070 versus 1.860) than RECIST 1.1 categorization. Multiple regression analysis demonstrated QVS of lesion size correlated most closely with PFS among the variables assessed (r=0.519, p<0.0001). QVS in this study was superior to standard RECIST categorization in terms of discriminating treated metastatic melanoma patients likely to have longer PFS.

AB - To assess whether quantitative visual scoring (QVS) is a better early predictor of progression-free survival (PFS) in patients on chemotherapy for metastatic melanoma using CT than the currently used Response Evaluation Criteria in Solid Tumors (RECIST) standard. Retrospective evaluation of 65 consecutive patients with metastatic melanoma on treatment who had a baseline and follow-up CT after two cycles of therapy. QVS was used to code imaging findings on the radiology reports considering size change, brain metastases, new lesions, mixed lesion response, and the number of organ systems involved. RECIST 1.1 criteria placed patients in the progressive disease, stable disease, or partial response groups. Multiple regression analysis was used to correlate the various independent variables with PFS. The Cox hazard proportions ratio, median survival, and Kaplan-Meier curves of the different prognostic groups were calculated. QVS of size change was found more sensitive in detecting patients deteriorating (57.1% versus 37.5%) or improving (23.8% versus 10.7%), more correlated with the median PFS for the deteriorating (1.8 versus 1.7 months), stable (5.6 versus 4.0 month), and improving (8.3 versus 5.5 months) categories and more predictive of PFS (Cox hazard proportion ratio of 3.070 versus 1.860) than RECIST 1.1 categorization. Multiple regression analysis demonstrated QVS of lesion size correlated most closely with PFS among the variables assessed (r=0.519, p<0.0001). QVS in this study was superior to standard RECIST categorization in terms of discriminating treated metastatic melanoma patients likely to have longer PFS.

KW - Body imaging

KW - Cancer detection

KW - Clinical oncology

KW - Computed tomography

KW - Health services research

KW - Image analysis

KW - Image perception

KW - Structured reporting

KW - Visual perception

UR - http://www.scopus.com/inward/record.url?scp=84861630916&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861630916&partnerID=8YFLogxK

U2 - 10.1007/s10278-011-9407-9

DO - 10.1007/s10278-011-9407-9

M3 - Article

VL - 25

SP - 258

EP - 265

JO - Journal of Digital Imaging

JF - Journal of Digital Imaging

SN - 0897-1889

IS - 2

ER -